Malgie, Jishnu http://orcid.org/0009-0001-1561-3542
Clephas, Pascal R. D.
Brunner-La Rocca, Hans-Peter
de Boer, Rudolf A.
Brugts, Jasper J.
Article History
Accepted: 31 May 2023
First Online: 14 June 2023
Declarations
:
: The manuscript does not contain clinical studies or patient data.
: J. Malgie: The author has no relevant financial or non-financial interests to disclose. P.R.D. Clephas: The author has no relevant financial or non-financial interests to disclose. J.J. Brugts: No relevant financial conflicts of interest. Speaker fees from Novartis, Vifor, and Abbott and advisory boards for Boerhinger, Bayer, and Astra Zenica. R.A. De Boer: received research grants and/or fees from AstraZeneca, Abbott, Boehringer Ingelheim, Cardior Pharmaceuticals GmbH, Ionis Pharmaceuticals, Inc., Novo Nordisk, and Roche; and has had speaker engagements with Abbott, AstraZeneca, Bayer, Bristol Myers Squibb, Novartis, and Roche. H.P. Brunner-La Rocca: unrestricted research grants from Novartis, Roche Diagnostics, Vifor; speaker fees from Boehringer-Ingelheim, AstraZeneca, Vifor, Novartis, Roche Diagnostics.